The University of Chicago Header Logo

Search Results (21)

MatchTypeWhy
MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia.Academic Article Why?
Chronic myelogenous leukemia, BCR-ABL1+.Academic Article Why?
MLL Rearrangment and EVI1 Deletion in BCR/ABL1 Positive Chronic Myeloid Leukemia.Academic Article Why?
Detection and quantification of BCR-ABL1 fusion transcripts by droplet digital PCR.Academic Article Why?
Template for Reporting Results of Monitoring Tests for Patients With Chronic Myelogenous Leukemia (BCR-ABL1(+)).Academic Article Why?
Gurbuxani, SandeepPerson Why?
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.Academic Article Why?
BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.Academic Article Why?
Cytogenetic, fluorescence in situ hybridization, and genomic array characterization of chronic myeloid leukemia with cryptic BCR-ABL1 fusions.Academic Article Why?
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity.Academic Article Why?
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.Academic Article Why?
Joseph, LorenPerson Why?
Liao, JamesPerson Why?
Vardiman, JamesPerson Why?
Arber, DanielPerson Why?
Per Page    Page  of 2last Nextnext
Prev
Search Criteria
  • B
  • BCR
  • ABL1
  • like
Filter by Type
_
Click "Why?" to see why an item matched the search.